Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Plotz

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
The American Journal of Medicine|May 1, 1978
Reduction of renal function by newer nonsteroidal anti-inflammatory drugsR P Kimberly, R E Bowden, H R Keiser, et al.
Clinical and Experimental Rheumatology|May 26, 1999
Inclusion body myositis long after dermatomyositis: a report of two casesA L McCoy, M R Bubb, P H Plotz, et al.
Journal of Autoimmunity|June 1, 1994
The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytesT P O'Hanlon, M C Dalakas, P H Plotz, et al.
Neuromuscular Disorders : NMD|February 13, 2001
Workshop on inflammatory myopathy Bethesda, 5-6 April 2000P H Plotz, F Miller, E Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathiesT P O'Hanlon, M C Dalakas, P H Plotz, et al.
Progress in Liver Diseases|January 1, 1976
Current status of artificial hepatic support systemsP D Berk, J F Martin, B F Scharschmidt, et al.
Proceedings of the Association of American Physicians|May 1, 1997
The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseasesE M Adams, J Kirkley, G Eidelman, et al.
JAMA|October 23, 1981
Clinical significance of low creatine phosphokinase values in patients with connective tissue diseasesN Wei, N Pavlidis, G Tsokos, et al.
Autophagy|July 3, 2009
The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' menShoichi Takikita, Rachel Myerowitz, Cynthia Schreiner, et al.
Arthritis and Rheumatism|June 1, 1996
Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritisK S Kanik, C H Yarboro, Y Naparstek, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|May 1, 1978
Reduction of renal function by newer nonsteroidal anti-inflammatory drugsR P Kimberly, R E Bowden, H R Keiser, et al.
Clinical and Experimental Rheumatology|May 26, 1999
Inclusion body myositis long after dermatomyositis: a report of two casesA L McCoy, M R Bubb, P H Plotz, et al.
Journal of Autoimmunity|June 1, 1994
The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytesT P O'Hanlon, M C Dalakas, P H Plotz, et al.
Neuromuscular Disorders : NMD|February 13, 2001
Workshop on inflammatory myopathy Bethesda, 5-6 April 2000P H Plotz, F Miller, E Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathiesT P O'Hanlon, M C Dalakas, P H Plotz, et al.
Progress in Liver Diseases|January 1, 1976
Current status of artificial hepatic support systemsP D Berk, J F Martin, B F Scharschmidt, et al.
Proceedings of the Association of American Physicians|May 1, 1997
The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseasesE M Adams, J Kirkley, G Eidelman, et al.
JAMA|October 23, 1981
Clinical significance of low creatine phosphokinase values in patients with connective tissue diseasesN Wei, N Pavlidis, G Tsokos, et al.
Autophagy|July 3, 2009
The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' menShoichi Takikita, Rachel Myerowitz, Cynthia Schreiner, et al.
Arthritis and Rheumatism|June 1, 1996
Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritisK S Kanik, C H Yarboro, Y Naparstek, et al.
Pageof 18